Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Head and Neck Neoplasms 5Stomatitis 3Neoplasms 3Mucositis 3Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Oral Ulcer 1Laryngeal Diseases 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 13Cetuximab 10Radiotherapy 7pembrolizumab 4Pemetrexed 4Fluorouracil 4Docetaxel 4Gemcitabine 3durvalumab 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Narrow Band Imaging 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gefitinib 2Drug Therapy 2Carboplatin 2tremelimumab 1niraparib 1monalizumab 1linrodostat 1dostarlimab 1capmatinib 1X-Rays 1Vitamin B 12 1Tirapazamine 1Tablets 1Surgical Flaps 1Sugars 1Radiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Diseases × Fibroblast Growth Factor 7 × Head & Neck × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡